Hunting Hill Global Capital’s Cano Health, Inc. CANO Stock Holding History

Hunting Hill Global Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-164	Closed	-$14.9K	–	121
2023 Q1	$14.9K	Sell	164 -254	-61%	-$34.5K	0.01%	57
2022 Q4	$57.3K	Buy	+418	New	+$142K	0.04%	59

Other funds holding CANO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Hunting Hill Global Capital's CANO Position: Q2 2023 in Review

Hunting Hill Global Capital sold out of Cano Health, Inc. (CANO) in Q2 2023, closing a stake of 164 shares — an estimated $14.9K sold.

Hunting Hill Global Capital first reported a position in CANO in Q4 2022 and held it in 2 quarters. The position peaked at $57.3K in Q4 2022. 154 funds tracked by Wall St. Rank hold CANO as of Q2 2023.

Hunting Hill Global Capital reported no remaining Cano Health, Inc. position as of Q2 2023 after selling out during the quarter.
Hunting Hill Global Capital sold 164 Cano Health, Inc. shares in Q2 2023, an estimated $14.9K.
Hunting Hill Global Capital first reported a position in Cano Health, Inc. in Q4 2022 and held it in 2 quarters.
Hunting Hill Global Capital's Cano Health, Inc. position peaked at $57.3K in Q4 2022.
154 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2023.

Based on Hunting Hill Global Capital's 13F filing for Q2 2023, filed 14 Aug 2023.